Glycobiology Market Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020 - 2027
Glycobiology is the study of the entire biology of molecules containing carbohydrates (sugar and saccharides), also known as glycans. It is extremely useful in biotechnology research and biomedicine. Carbohydrates regulate almost all aspects of cellular processing, including cell-cell interactions, adhesion mechanisms, signalling for growth factors, blood clotting, hormonal activity regulation, and embryonic development.
The Glycobiology Market is in its early stages, owing to an increase in R&D spending by various pharmaceutical companies. In addition, activities such as drug discovery, government spending, technological advancement, public and private investments, and grants and funds for the development of more advanced technologies in the field of R&D are on the rise. However, factors such as the high cost of the imaging process, stringent government policies, and a scarcity of skilled technicians stymie market growth.
The rising prevalence of chronic diseases, as well as an increase in product launches by key companies, are expected to drive growth in the global glycobiology market during the forecast period. The increasing number of product launches, such as mass spectrometry devices and high-profile liquid chromatography (HPLC) devices, is expected to drive global glycobiology market growth over the forecast period. For example, Thermo Fisher Scientific Inc. announced the release of the Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 mass spectrometers in May 2020. Proteins and peptides are identified using spectrometers.
Due to the overall increasing use of enzymes in cancer research and diagnostics, the Enzymes segment is expected to account for a significant revenue share over the forecast period. Glycosidases, among other enzymes, are expected to contribute significantly to this segment's revenue growth due to their growing use in oncology research and therapeutic approaches for diseases caused by deficiencies.
The major players operating in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, Agilent Technologies, Inc.
Comments
Post a Comment